GSK takes over Novartis' troubled OTC plant; China wants drug distribution reforms;

> GlaxoSmithKline ($GSK) now has control of the troubled Novartis ($NVS) OTC plant in Lincoln, NE, as part of their new consumer health JV. Story

> Mapi Group has added pharma regulatory consulting services, CanReg Group, after its acquisition this year of the North American and European regulatory consulting services of Optum Life Sciences. Release

> China's government is suggesting drugmakers cut middlemen out of the processing selling their drugs in an effort to cut costs and reduce corruption. Story

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.